Carerx Corp Stock Beneish M Score

CRRX Stock  CAD 1.88  0.05  2.73%   
This module uses fundamental data of CareRx Corp to approximate the value of its Beneish M Score. CareRx Corp M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CareRx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
At this time, CareRx Corp's Total Debt To Capitalization is very stable compared to the past year. As of the 29th of November 2024, Debt Ratio is likely to grow to 0.41, while Short Term Debt is likely to drop about 11.8 M. At this time, CareRx Corp's Net Debt To EBITDA is very stable compared to the past year. As of the 29th of November 2024, Current Ratio is likely to grow to 1.65, while Price To Sales Ratio is likely to drop 0.24.
At this time, CareRx Corp's M Score is inapplicable. The earnings manipulation may begin if CareRx Corp's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by CareRx Corp executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of CareRx Corp's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.58
Beneish M Score - Inapplicable
Elasticity of Receivables

0.59

Focus
Asset Quality

0.81

Focus
Expense Coverage

0.89

Focus
Gross Margin Strengs

1.71

Focus
Accruals Factor

0.89

Focus
Depreciation Resistance

1.45

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

1.3

Focus

CareRx Corp Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if CareRx Corp's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables22.2 M36.1 M
Way Down
Pretty Stable
Total Revenue389.3 M370.7 M
Sufficiently Up
Pretty Stable
Total Assets178.4 M231.9 M
Significantly Down
Slightly volatile
Total Current Assets52.8 M65.4 M
Significantly Down
Very volatile
Non Current Assets Total125.6 M166.5 M
Way Down
Slightly volatile
Property Plant Equipment63.3 M60.3 M
Sufficiently Up
Slightly volatile
Depreciation And Amortization13.2 M20 M
Way Down
Pretty Stable
Selling General Administrative28.8 M30.7 M
Notably Down
Pretty Stable
Total Current Liabilities60 M62.4 M
Sufficiently Down
Slightly volatile
Non Current Liabilities Total102.5 M87.9 M
Fairly Up
Pretty Stable
Short Term Debt11.8 M12.4 M
Notably Down
Slightly volatile
Short Term Investments399.2 K449.1 K
Fairly Down
Slightly volatile
Gross Profit Margin0.390.2285
Way Up
Slightly volatile

CareRx Corp Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between CareRx Corp's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards CareRx Corp in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find CareRx Corp's degree of accounting gimmicks and manipulations.

About CareRx Corp Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

13.17 Million

At this time, CareRx Corp's Depreciation And Amortization is very stable compared to the past year.

CareRx Corp Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as CareRx Corp. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables12.6M15.4M38.1M37.3M36.1M22.2M
Total Revenue124.6M162.2M262.6M381.7M370.7M389.3M
Total Assets87.1M156.1M282.8M264.5M231.9M178.4M
Total Current Assets19.1M45.2M95.2M89.2M65.4M52.8M
Net Debt66.2M62.6M89.9M106.9M89.8M92.7M
Short Term Debt45.6M6.1M1.3M10.0M12.4M11.8M
Long Term Debt13.0M71.9M112.0M99.4M57.1M59.3M
Operating Income(2.8M)(2.9M)4.7M7.9M7.2M7.6M
Investments33.8M(4.2M)(93.2M)(16.6M)(12.3M)(11.7M)

About CareRx Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CareRx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Other Information on Investing in CareRx Stock

CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.